| Name | Title | Contact Details |
|---|
NCD Corporation is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sysmex America, Inc. distributes and supports automated `in vitro` diagnostic hematology, coagulation and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere.? The company was formerly known as Sysmex Corporation Of America and changed its name to Sysmex America, Inc. in June 2003. The company was founded in 1979 and is based in Lincolnshire, Illinois. Sysmex America, Inc. operates as a subsidiary of Sysmex Corp.
Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.
Aerolase designs, manufactures and markets the LightPod family of lasers, which represent a technology breakthrough in the field of laser medicine. The result is a new generation of aesthetic and dermatology lasers, built on the proven safety and versatility of gold-standard medical laser modalities. LightPod lasers deliver the highest power for aesthetic & dermatology treatments with uniquely optimized laser pulse parameters based on clinical research. They lead the industry with an unprecedented combination of Efficacy, Safety, Versatility, and Return on Investment.
CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. At CHF Solutions, we are committed to the relentless pursuit of identifying and developing innovative solutions to address unmet clinical needs with the goal of benefiting patients, medical practitioners, and the broader healthcare community.